Table 3.
Outcome characteristics of patients with invasive infection due to MRSA with vancomycin MICs of 2 μg/ml from 5 U.S. statesa
| Outcome | n (%) | Median | Range |
|---|---|---|---|
| MRSA-related complicationsb | 48 (35) | ||
| Type of complicationc | |||
| Sepsis | 32 (67) | ||
| Acute renal failure | 11 (23) | ||
| Endocarditis | 5 (10) | ||
| Internal abscess | 5 (10) | ||
| Thrombotic event | 4 (8) | ||
| Osteomyelitis | 4 (8) | ||
| In-hospital mortality | 23 (17) | ||
| Recurrent MRSA disease | 16 (12) | ||
| Length of hospital stay (days)d (n = 105) | 14 | 1–193 |
a
Data from the Active Bacterial Core Surveillance for Invasive MRSA Project (n = 138).
b
Occurring between 3 and 30 days after initial culture.
c
Not mutually exclusive.
d
Among those who survived hospitalization and were hospitalized.